Taken together, these results highlight the importance of the HDAC6/Sp1 axis in the DDR pathway, suggesting that targeting HDAC6/Sp1 signaling is an effective strategy against GBM and recurrent GBM with higher DNA repair capacity. Here, SP1 is linked to glioblastoma.